No revenue reported as Terns remains a clinical-stage, pre-commercial biotech. A strong cash position of $315.4 million as of Q2 2025 is expected to fund operations into 2028.

Doustdar said last week the company will pursue "savings and efficiencies." Investors have questioned whether Novo Nordisk ...

Bayer, the German pharmaceutical and biopharma group, has said that it has cut up... Danish drugmaker Novo Nordisk is to cut costs after slipping down the list of most... Passenger number records were ...

Novo Nordisk has announced the filing of 14 new lawsuits against the sale of unapproved compounded drugs claiming to contain semaglutide.

Investor Deadline: Investors who purchased or acquired Novo securities between May 7, 2025 through July 28, 2025 (the “Class Period”), may, no later than September 30, 2025, seek to be appointed as a ...

Danish drugmaker Novo Nordisk is to cut costs after slipping down the list of most... Passenger number records were broken at Dublin and Cork airports in July, with the... Irish-founded Tullow Oil has ...

The U.S. dollar remained under pressure as expectations build for a potential Federal Reserve rate cut in September.

Danish pharmaceutical giant Novo Nordisk posted a sharp rise in second-quarter net profit today, but rising competition is ...

Novo Nordisk Philippines and Doctor Anywhere Philippines recently formalized their partnership to strengthen the fight ...

Novo Nordisk, the maker of Wegovy, plans to cut costs and refocus commercially after a $95 billion stock loss. The company's market cap has dropped to around $212 billion.

Glencore Earnings Fall on Lower Coal Prices, Copper Production Challenges The commodities giant said the results reflect lower coal prices and a drop in copper production following operational ...